{"id":"https://openalex.org/W2995048060","doi":"https://doi.org/10.1182/bloodadvances.2019001016","title":"Allo-HSCT in transplant-na\u00efve patients with Hodgkin lymphoma: a single-arm, multicenter study","display_name":"Allo-HSCT in transplant-na\u00efve patients with Hodgkin lymphoma: a single-arm, multicenter study","publication_year":2019,"publication_date":"2019-12-23","ids":{"openalex":"https://openalex.org/W2995048060","doi":"https://doi.org/10.1182/bloodadvances.2019001016","mag":"2995048060","pmid":"https://pubmed.ncbi.nlm.nih.gov/31869413","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6929392"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2019001016","doi":"https://doi.org/10.1182/bloodadvances.2019001016","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2019001016","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/3/24/4264/1549966/advancesadv2019001016.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/3/24/4264/1549966/advancesadv2019001016.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052712961","display_name":"Emma P. Das-Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emma Das-Gupta","raw_affiliation_strings":["Nottingham University Hospital, Nottingham, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham University Hospital, Nottingham, United Kingdom;","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102957013","display_name":"Kirsty J. Thomson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kirsty J. Thomson","raw_affiliation_strings":["University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025217094","display_name":"Adrian John Clifton Bloor","orcid":"https://orcid.org/0000-0003-4550-220X","observed_orcids":["https://orcid.org/0000-0003-4550-220X"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian J. C. Bloor","raw_affiliation_strings":["The Christie NHS Foundation Trust, Manchester, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Christie NHS Foundation Trust, Manchester, United Kingdom;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew D. Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew D. Clark","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041242319","display_name":"Stephen Mackinnon","orcid":"https://orcid.org/0000-0002-6289-4295","observed_orcids":["https://orcid.org/0000-0002-6289-4295"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Mackinnon","raw_affiliation_strings":["Department of Haematology, UCL Cancer Institute, London, United Kingdom; and","Royal Free Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, UCL Cancer Institute, London, United Kingdom; and","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Royal Free Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I2801138448"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002532852","display_name":"Irfan A. Kayani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Irfan Kayani","raw_affiliation_strings":["University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050819642","display_name":"Laura Clifton\u2010Hadley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Clifton-Hadley","raw_affiliation_strings":["Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109033170","display_name":"Pip Patrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Pip Patrick","raw_affiliation_strings":["Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072156718","display_name":"Nadjet El-Mehidi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nadjet El-Mehidi","raw_affiliation_strings":["Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088142566","display_name":"Anthony Lawrie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anthony Lawrie","raw_affiliation_strings":["Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018708168","display_name":"Amy A. Kirkwood","orcid":"https://orcid.org/0000-0003-0133-7732","observed_orcids":["https://orcid.org/0000-0003-0133-7732"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amy A. Kirkwood","raw_affiliation_strings":["Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035489508","display_name":"Nigel H. Russell","orcid":"https://orcid.org/0000-0003-1893-8155","observed_orcids":["https://orcid.org/0000-0003-1893-8155"]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nigel H. Russell","raw_affiliation_strings":["Nottingham University Hospital, Nottingham, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham University Hospital, Nottingham, United Kingdom;","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005708709","display_name":"David C. Linch","orcid":"https://orcid.org/0000-0002-9988-5528","observed_orcids":["https://orcid.org/0000-0002-9988-5528"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David C. Linch","raw_affiliation_strings":["Department of Haematology, UCL Cancer Institute, London, United Kingdom; and","University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, UCL Cancer Institute, London, United Kingdom; and","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111847229","display_name":"Karl S. Peggs","orcid":"https://orcid.org/0000-0001-5831-3972","observed_orcids":["https://orcid.org/0000-0001-5831-3972"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karl S. Peggs","raw_affiliation_strings":["Department of Haematology, UCL Cancer Institute, London, United Kingdom; and","University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, UCL Cancer Institute, London, United Kingdom; and","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"University College London (UCL) Hospitals National Health Service (NHS) Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":0.6977,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.73075999,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"3","issue":"24","first_page":"4264","last_page":"4270"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.8633000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.8633000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.12950000166893005,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.925000011920929},{"id":"https://openalex.org/keywords/relapsed-refractory-hodgkin-lymphoma","display_name":"relapsed/refractory Hodgkin lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pet-ct","display_name":"PET/CT","score":0.41999998688697815},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.7059999704360962},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.9070000052452087},{"id":"https://openalex.org/keywords/donor-lymphocyte-infusion","display_name":"donor lymphocyte infusion","score":0.8960000276565552},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9419999718666077},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.8240000009536743},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8740000128746033},{"id":"https://openalex.org/keywords/mixed-chimerism","display_name":"mixed chimerism","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7234039306640625},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.6332694292068481},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5940055847167969},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.5626991987228394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5494182109832764},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48355433344841003},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3472534418106079},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.0714484453201294}],"mesh":[{"descriptor_ui":"D000072078","descriptor_name":"Positron Emission Tomography Computed Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1182/bloodadvances.2019001016","doi":"https://doi.org/10.1182/bloodadvances.2019001016","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2019001016","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/3/24/4264/1549966/advancesadv2019001016.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6929392","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6929392","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:31869413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31869413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10090494","doi":null,"is_oa":true,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10090494/","pdf_url":"https://discovery.ucl.ac.uk/id/eprint/10090494/3/Peggs_advancesadv2019001016.pdf","source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood Advances , 3 (24) pp. 4264-4270. (2019)","raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:fcbef3681889418ebbc0e8a61fd4114f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/fcbef3681889418ebbc0e8a61fd4114f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood Advances, Vol 3, Iss 24, Pp 4264-4270 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2019001016","doi":"https://doi.org/10.1182/bloodadvances.2019001016","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2019001016","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/3/24/4264/1549966/advancesadv2019001016.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310960","display_name":"NHS Blood and Transplant","ror":"https://ror.org/0227qpa16"},{"id":"https://openalex.org/F4320316282","display_name":"Queen Elizabeth Hospital Birmingham Charity","ror":"https://ror.org/048emj907"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320286","display_name":"University College London","ror":"https://ror.org/02jx3x895"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2995048060.pdf","grobid_xml":"https://content.openalex.org/works/W2995048060.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1860199933","https://openalex.org/W1978849352","https://openalex.org/W1997194652","https://openalex.org/W2041032819","https://openalex.org/W2062486240","https://openalex.org/W2078832083","https://openalex.org/W2111070506","https://openalex.org/W2111613096","https://openalex.org/W2157717016","https://openalex.org/W2169944840","https://openalex.org/W2346010008","https://openalex.org/W2473773035","https://openalex.org/W2537884769","https://openalex.org/W2558248073","https://openalex.org/W2567998110","https://openalex.org/W2592540477","https://openalex.org/W2594496276","https://openalex.org/W2745549673","https://openalex.org/W2797000102","https://openalex.org/W2892881565"],"related_works":["https://openalex.org/W2169944840","https://openalex.org/W2969759193","https://openalex.org/W2559280771","https://openalex.org/W3029550323","https://openalex.org/W4401011824","https://openalex.org/W4312394266","https://openalex.org/W4387424856","https://openalex.org/W2603915097","https://openalex.org/W1969631111","https://openalex.org/W7211985266"],"abstract_inverted_index":{"We":[0,230],"evaluated":[1],"the":[2,206],"role":[3,238],"of":[4,32,55,81,126,135,178,205,225],"allogeneic":[5],"hematopoietic":[6],"stem":[7],"cell":[8],"transplantation":[9,196],"(allo-HSCT)":[10],"in":[11,60,187,215,241],"transplant-na\u00efve":[12],"patients":[13,103,136,208,244],"with":[14,35,62,72,173,189,220,245],"relapsed/refractory":[15],"Hodgkin":[16],"lymphoma":[17],"(HL)":[18],"who":[19,209],"failed":[20],"to":[21,27,29,52,68,70,140],"attain":[22],"metabolic":[23],"complete":[24],"response":[25],"(mCR)":[26],"1":[28,51],"2":[30,53,139],"lines":[31],"salvage":[33,56],"chemotherapyThose":[34],"residual":[36,98,190],"but":[37],"nonprogressive":[38],"disease":[39,64,131,193],"assessed":[40],"by":[41],"positron":[42],"emission":[43],"tomography/computed":[44],"tomography":[45],"scanning":[46],"were":[47,58,92,119,185],"eligible.":[48],"An":[49],"additional":[50,73],"cycles":[54],"therapy":[57],"permissible":[59],"those":[61,188],"progressive":[63],"or":[65,97,99],"when":[66],"required":[67],"bridge":[69],"allo-HSCT,":[71],"imaging":[74],"at":[75,217,251],"baseline":[76],"before":[77,195],"transplantation.":[78],"Conditioning":[79],"consisted":[80],"carmustine,":[82],"etoposide,":[83],"cytarabine,":[84],"melphalan,":[85],"and":[86,112,123,143,213],"alemtuzumab.":[87],"Donor":[88],"lymphocyte":[89],"infusions":[90],"(DLI)":[91],"administered":[93],"for":[94,239],"mixed":[95],"chimerism":[96],"relapsed":[100,210],"disease.":[101],"Eleven":[102],"had":[104,108,114,137,145],"sibling":[105],"donors,":[106,111],"13":[107],"HLA-matched":[109],"unrelated":[110,116],"7":[113],"HLA-mismatched":[115],"donors.":[117],"There":[118],"no":[120,124],"graft":[121],"failures,":[122],"episodes":[125],"grade":[127,138],"4":[128],"acute":[129],"graft-versus-host":[130],"(GVHD);":[132],"only":[133],"19.4%":[134],"3":[141],"GVHD,":[142],"22.2%":[144],"extensive":[146],"chronic":[147],"GVHD.":[148],"The":[149,167],"non-relapse":[150],"mortality":[151],"rate":[152],"was":[153,162,249],"16.1%":[154],"(95%":[155,164,180,227],"confidence":[156],"interval":[157],"[CI],":[158],"7.1%-34.5%).":[159],"Relapse":[160],"incidence":[161],"18.7%":[163],"CI,":[165,181,202,228],"8.2%-39.2%).":[166],"study":[168],"met":[169],"its":[170],"primary":[171],"objective,":[172],"a":[174,221,236],"3-year":[175,222],"progression-free":[176],"survival":[177,224],"67.7%":[179],"48.4%-81.2%).":[182],"Survival":[183],"outcomes":[184],"equivalent":[186],"metabolically":[191],"active":[192],"immediately":[194],"(n":[197],"=":[198],"24":[199],"[70.8%;":[200],"95%":[201],"17.2%-83.7%]).":[203],"Two":[204],"5":[207],"received":[211],"DLI":[212],"remained":[214],"mCR":[216],"latest":[218],"follow-up,":[219],"overall":[223],"80.7%":[226],"61.9%-90.8%).":[229],"demonstrate":[231],"encouraging":[232],"results":[233],"that":[234],"establish":[235],"potential":[237],"allo-HSCT":[240],"selected":[242],"high-risk":[243],"HL.":[246],"This":[247],"trial":[248],"registered":[250],"www.clinicaltrials.gov":[252],"as":[253],"#NCT00908180.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-12-26T00:00:00"}